This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CONNECTIVE_SOFT_NAS_EXALLC for full statistics.
Malignant neoplasm of other connective and soft tissue
C3_CONNECTIVE_SOFT_NAS
lip cancer: Tumors or cancer of the LIP.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
822 |
4. Check minimum number of eventsNone |
822 |
5. Include endpointsNone |
822 |
6. Filter based on genotype QC (FinnGen only) |
822 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other connective and soft tissue
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 822 | 377 | 445 |
| Unadjusted period prevalence (%) | 0.17 | 0.13 | 0.20 |
| Median age at first event (years) | 63.28 | 61.32 | 64.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 735
- Matched controls
- 7349
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
119.1
111
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
110.2
103
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
106.9
100
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
29.9
90.6
123
49
130
Kela drug reimbursment
Malignant tumour
8.3
90.5
224
367
JN4BD
NOMESCO Finland
Extensive body CT
6.8
84.4
246
506
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
32.2
81.3
108
39
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
91.0
73.7
81
10
A03FA01
ATC
metoclopramide; systemic, rectal
4.8
70.4
294
894
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
65.6
62
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
64.5
61
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
58.2
469
2426
WF003
NOMESCO Finland
Adjuvant radiotherapy
13.0
58.1
106
94
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
98.3
57.9
63
7
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
26.3
57.2
80
34
L03AA02
ATC
filgrastim; parenteral
13.4
56.3
101
86
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.1
55.1
132
193
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.4
53.6
116
143
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.8
52.8
119
157
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
51.7
49
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
133.9
47.4
50
*
H02AB02
ATC
dexamethasone; systemic
5.0
46.3
165
399
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
43.1
41
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.1
42.4
110
178
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
71.5
41.6
47
7
L03AA13
ATC
pegfilgrastim; parenteral
9.1
40.7
89
110
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
34.9
40.3
52
16
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
38.9
37
*
A04AA02
ATC
granisetron; systemic, transdermal
5.7
38.5
119
241
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
13.8
38.3
67
53
A04AA01
ATC
ondansetron; systemic, rectal
6.1
38.1
111
209
N02AA05
ATC
oxycodone; systemic
3.6
37.9
205
717
8800/3-C49.2
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
36.8
35
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
363.8
35.3
35
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
34.7
33
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.1
34.3
74
89
R4120
NOMESCO Finland
Occupational therapy
5.6
34.1
106
215
ZZA00
NOMESCO Finland
Split skin graft
8.5
34.1
77
100
JN4AD
NOMESCO Finland
Body CT examination
4.7
34.1
125
305
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
33.6
32
*
159
Kela drug reimbursment
Pazopanib
177.9
33.0
34
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
32.2
143
418
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
10.7
32.0
63
64
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.4
31.3
77
114
R4110
NOMESCO Finland
Physiotherapy
2.7
31.3
273
1301
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
44.4
31.2
38
9
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
326.1
31.1
31
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
10.8
30.7
60
60
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.6
29.8
80
134
B01AB05
ATC
enoxaparin; parenteral
2.6
29.3
307
1610
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
13.6
29.3
51
40
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
29.1
269
1313
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
14.0
29.1
50
38
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
16.1
29.0
47
31
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
303.4
29.0
29
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
156.1
28.9
30
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
13.7
28.8
50
39
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
28.3
27
*
A04AD12
ATC
aprepitant; systemic
10.7
28.2
55
55
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
28.1
304
1612
L01XE11
ATC
[U] pazopanib; oral
292.1
27.9
28
*
WW500
NOMESCO Finland
Blood transfusion
5.7
27.1
81
156
WF001
NOMESCO Finland
Preoperative radiotherapy
17.7
26.9
42
25
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.6
26.9
100
245
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
12.1
26.8
49
43
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.3
26.7
106
277
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
16.2
26.7
43
28
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.1
26.5
88
191
ZX090
NOMESCO Finland
Other technic of radiotherapy
8.2
26.3
60
79
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
75.2
26.0
29
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
269.6
25.9
26
*
Z51.5
ICD-10 Finland
Palliative care
4.4
25.7
100
256
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.3
25.7
54
62
ZZR10
NOMESCO Finland
Flap of skin and muscle
28.7
24.7
33
12
XW000
NOMESCO Finland
Bone marrow biopsy
5.7
24.6
73
139
WF002
NOMESCO Finland
Radical radiotherapy
4.9
24.6
84
188
L03AA14
ATC
lipegfilgrastim; parenteral
9.1
24.5
52
61
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
24.1
23
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
24.1
23
*
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
24.1
23
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
129.2
23.7
25
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
10.6
23.6
46
46
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.5
23.4
62
102
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
23.0
22
*
C49.90
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue without histology
+∞
22.0
21
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
22.0
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
21.9
325
1945
N03AX16
ATC
pregabalin; oral
2.5
21.9
217
1070
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
27.4
21.5
29
11
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.2
21.2
58
100
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.1
21.1
42
44
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
20.9
20
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
38.4
20.9
26
7
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.5
20.4
54
89
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
12.6
20.2
36
30
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
19.9
19
*
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.9
19
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
19.9
19
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
19.7
329
2048
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
108.0
19.7
21
*
343
Kela drug reimbursment
Pazopanib
108.0
19.7
21
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
20.1
19.6
29
15
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
18.8
18
*
B01AB10
ATC
tinzaparin; parenteral
3.5
18.2
90
283
WZC30
NOMESCO Finland
Teaching
2.7
17.4
134
566
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.6
17.2
37
45
JN4CD
NOMESCO Finland
Very extensive body CT
4.5
17.0
61
144
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.6
16.9
78
232
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
16.8
69
185
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
64.9
16.8
19
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
16.7
122
499
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
36.0
16.7
21
6
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
16.7
16
*
C49.3
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of thorax
+∞
16.7
16
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
16.7
16
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
16.7
78
234
GA1CG
NOMESCO Finland
Extensive MRI of chest
92.2
16.6
18
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
16.6
65
167
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.0
16.5
68
183
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
17.2
16.2
25
15
WX402
NOMESCO Finland
General anaesthesia
2.4
15.9
149
699
8802/3-C49.2
ICD-O-3
Giant cell sarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
15.7
15
*
C49.9
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue, unspecified
+∞
15.7
15
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
15.7
15
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
87.0
15.6
17
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
163.3
15.5
16
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.3
15.4
47
93
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
7.5
15.4
36
50
ZXE00
NOMESCO Finland
One hour or less
1.9
15.4
314
2050
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.5
15.3
24
15
ZZR00
NOMESCO Finland
Flap of skin
5.3
15.0
46
92
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
5.8
14.9
42
76
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
6.0
14.9
41
72
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
57.9
14.8
17
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
14.7
137
640
C49.09
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck other or unspecified tumor
+∞
14.6
14
*
8800/3-C49.1
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
14.6
14
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
81.8
14.6
16
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
14.5
64
183
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
152.9
14.5
15
*
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
36.8
14.5
18
5
JN6AD
NOMESCO Finland
CT of torso and neck
8.9
14.3
30
35
WF004
NOMESCO Finland
Palliative radiotherapy
6.4
14.3
37
60
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.2
14.2
44
89
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
14.0
56
147
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.0
13.6
55
146
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
13.6
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.6
13
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
13.6
13
*
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
13.6
13
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
13.6
13
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.3
13.5
68
217
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.9
13.5
37
65
R50.9
ICD-10 Finland
Fever, unspecified
2.4
13.4
128
600
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
21.6
13.4
19
9
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.9
13.3
55
149
N02BE01
ATC
paracetamol; systemic, rectal
2.1
12.9
625
5367
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
12.9
175
966
A79
ICPC
Malignancy NOS
8.0
12.7
28
36
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
9040/3-C49.2
ICD-O-3
Synovial sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
C49.5
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of pelvis
+∞
12.5
12
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.8
12.5
35
63
1XC02
NOMESCO Finland
NA
13.5
12.5
21
16
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
132.2
12.5
13
*
JAH00
NOMESCO Finland
Laparotomy
4.9
12.3
40
86
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
27.2
12.1
16
6
189
Kela drug reimbursment
Imatinib
47.5
11.9
14
*
S18
ICPC
Laceration/cut
1.8
11.8
324
2277
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.9
11.8
32
56
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
11.7
62
206
GA1BG
NOMESCO Finland
MRI of chest
66.0
11.6
13
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
23.3
11.6
16
7
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.5
11
*
C49
ICD-10 Finland
Malignant neoplasm of other connective and soft tissue
+∞
11.5
11
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
11.5
11
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
11.5
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.5
11
*
C49.0
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of head, face and neck
+∞
11.5
11
*
L01XE01
ATC
[U] imatinib; oral
121.8
11.5
12
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
121.8
11.5
12
*
ZX120
NOMESCO Finland
Intravenous
2.5
11.4
91
389
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
15.3
11.3
18
12
L71
ICPC
Malignant neoplasm musculoskeletal
35.6
11.3
14
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
11.1
162
913
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
11.1
102
470
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.9
141
758
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
12.2
10.9
19
16
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
15.8
10.9
17
11
ZXA05
NOMESCO Finland
Left side
1.8
10.8
208
1296
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
10.8
55
178
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.9
10.7
66
242
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
10.2
10.6
20
20
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.4
10
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
10.4
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.4
10
*
C49.60
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue at the torso, unspecified location without histology
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
YN1CD
NOMESCO Finland
Very extensive CT examination of extremities for dose design of radiotherapy
+∞
10.4
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.4
10
*
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
10.4
10
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
10.4
10
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
16.3
10.4
16
10
A02BC02
ATC
pantoprazole; systemic
1.7
10.3
465
3721
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
4.4
10.2
36
85
ZZR30
NOMESCO Finland
Flap of muscle
13.4
10.2
17
13
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.2
150
849
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
9.3
10.1
20
22
ZXA00
NOMESCO Finland
Right side
1.8
9.9
219
1422
R4190
NOMESCO Finland
Nutritional therapy
4.2
9.8
36
89
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
55.7
9.7
11
*
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
55.7
9.7
11
*
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
101.3
9.4
10
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
17.8
9.4
14
8
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
30.4
9.4
12
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
9.4
9
*
C49.50
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis without histology
+∞
9.4
9
*
C49.04
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck rhabdomyosarcoma
+∞
9.4
9
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
C49.31
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax malignant fibrotic histiocytoma
+∞
9.4
9
*
C49.98
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue Ewing's sarcoma
+∞
9.4
9
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.2
9.4
20
25
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
8.4
9.1
19
23
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
37.2
9.0
11
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.4
8.8
42
130
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.7
91
445
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
50.6
8.7
10
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
8.6
61
242
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.5
8.5
21
33
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
27.9
8.5
11
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
27.9
8.5
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
27.9
8.5
11
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.4
87
424
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.0
8.4
18
23
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.4
8.4
29
68
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
C49.18
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder Ewing's sarcoma
+∞
8.3
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.3
8
*
C49.69
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization other or unspecified tumor
+∞
8.3
8
*
NCR30
NOMESCO Finland
Extended excision of soft tissue tumour of elbow or forearm
+∞
8.3
8
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.3
8
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
11.9
8.1
14
12
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
33.7
8.1
10
*
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
22.3
8.0
11
5
WW300
NOMESCO Finland
Transfer of autologic stem cells
11.0
7.8
14
13
NF3AA
NOMESCO Finland
Femur X-ray examination
4.3
7.8
27
64
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
5.1
7.8
23
46
ZX112
NOMESCO Finland
Subcutaneous
4.3
7.7
27
65
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.6
302
2266
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.2
7.6
16
20
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
7.6
45
163
TQD05
NOMESCO Finland
Puncture of skin of lower limb
80.9
7.4
8
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
8.5
7.3
15
18
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.8
7.3
29
78
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
C49.24
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip rhabdomyosarcoma
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
8800/3-C49.6
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
GAE20
NOMESCO Finland
Resection of chest wall and repair using flap
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
7.3
7
*
C49.89
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue other or unspecified tumor
+∞
7.3
7
*
8800/3-C49.9
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
7.3
7
*
1713K
ICD-9 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN PEHMYTKUDOSSYÖPÄ,MUU HISTOL]
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.2
7.2
26
64
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
15.9
7.2
11
7
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.5
7.2
24
55
Z31.5
ICD-10 Finland
Genetic counselling
3.1
7.1
38
129
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.1
7.1
21
42
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
20.2
7.1
10
5
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.0
7.1
27
70
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.0
7.1
15
19
SPAT1153
SPAT
Removal of sutures
1.6
7.1
228
1619
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.4
7.1
24
56
M04AA01
ATC
allopurinol; systemic
1.9
7.1
114
662
J01MA12
ATC
levofloxacin; systemic
1.7
6.9
149
951
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
6.8
6.8
16
24
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
5.4
6.8
19
36
C82.1
ICD-10 Finland
Follicular lymphoma grade II
9.4
6.8
13
14
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
6.8
34
111
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.7
6.8
18
32
WW409
NOMESCO Finland
Other aferesis
40.4
6.8
8
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
40.4
6.8
8
*
Z2446
NOMESCO Finland
Social worker
2.3
6.8
59
266
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.0
6.7
25
64
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.8
6.6
26
70
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
12.4
6.6
11
9
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
12.4
6.6
11
9
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
10.1
6.5
12
12
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
6.5
74
378
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
70.4
6.4
7
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
70.4
6.4
7
*
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
70.4
6.4
7
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
70.4
6.4
7
*
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
70.4
6.4
7
*
NAR40
NOMESCO Finland
Block excision of soft tissue tumour of spine, unspecified
70.4
6.4
7
*
NC1DG
NOMESCO Finland
Elbow and forearm very extensive MRI examination with high intensity magnet
70.4
6.4
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
14.5
6.4
10
7
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
14.5
6.4
10
7
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
14.5
6.4
10
7
B01AB04
ATC
dalteparin; parenteral
2.5
6.4
48
200
Z3231
NOMESCO Finland
Registered nurse
1.6
6.4
201
1412
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.8
6.4
38
140
C49.40
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen without histology
+∞
6.3
6
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
6.3
6
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
6.3
6
*
C49.54
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis rhabdomyosarcoma
+∞
6.3
6
*
C49.91
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue malignant fibrotic histiocytoma
+∞
6.3
6
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
26.9
6.2
8
*
WX110
NOMESCO Finland
Local anesthesy
1.5
6.2
449
3784
A06AH03
ATC
naloxegol; oral
5.8
6.2
16
28
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
6.1
50
219
ZX080
NOMESCO Finland
Image guided radiotherapy
4.1
6.1
22
55
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
4.7
6.1
19
41
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.0
6.1
18
37
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.0
6.1
18
37
S04
ICPC
Lump/swelling localized
2.1
6.0
62
303
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
286
579
7.04
145.24
1.6
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
55
47
12.47
54.59
1.2
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
223
799
3.46
49.95
5.8
4.2
u/l
298.2
248.1
0.71
218
751
(3044640) Blood type and Crossmatch panel - Blood
415
2155
2.87
47.99
3.6
2.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
141
389
4.17
46.14
1.3
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
340
1636
2.84
44.74
3.4
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
522
3147
2.80
43.82
5.3
4.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
451
2531
2.73
43.56
3.0
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
263
1118
2.99
43.36
5.5
3.5
mmol/l
0.8
0.8
0.20
258
1047
(40768795) Lymph node Pathology biopsy report
51
61
8.85
39.84
1.5
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
560
3597
2.75
39.80
12.1
6.3
umol/l
11.0
11.8
0.70
547
3404
(3023368) Bacteria identified in Blood by Culture
370
2040
2.48
34.82
5.9
4.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
563
3779
2.55
33.96
19.3
8.9
e9/l
4.1
4.2
0.36
517
3307
(3033658) Prothrombin time (PT) actual/Normal
317
1686
2.43
31.62
5.4
4.0
%
89.9
86.8
1.62
310
1649
(3017143) Hepatitis C virus Ab [Presence] in Serum
159
609
3.00
30.57
1.6
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
470
3001
2.32
30.29
7.6
4.9
g/l
33.7
35.1
5.63
448
2790
(3002256) Pathology report gross observation
191
827
2.71
29.06
1.5
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
40
53
7.88
28.67
2.1
1.8
e9/l
0.8
1.1
0.74
31
27
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
37
9.54
28.43
2.0
1.7
%
17.0
14.3
0.31
15
20
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
33
36
9.51
27.54
2.1
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
299
1635
2.30
27.15
16.4
6.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
478
3167
2.22
26.93
9.0
6.2
mmol/l
1.2
1.2
0.09
452
2863
(3042936) Bacteria identified in Isolate by Culture
213
1024
2.46
25.76
2.2
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
164
697
2.69
25.63
1.7
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
449
2951
2.15
25.19
9.0
10.4
inr
1.2
1.3
1.31
118
831
(42870588) Differential panel, method unspecified - Blood
367
2232
2.16
25.19
7.6
5.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
499
3448
2.14
24.17
9.9
7.0
mmol/l
1.2
1.2
0.03
416
2918
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
251
1335
2.27
23.82
6.0
3.2
mmol/l
2.5
2.5
2.35
223
1181
(3015377) Calcium [Moles/volume] in Serum or Plasma
373
2321
2.11
23.73
8.2
3.5
mmol/l
2.4
2.4
0.21
334
2013
(3018418) pH of Serum or Plasma
339
2061
2.10
22.68
7.0
4.0
ph
7.4
7.4
0.25
81
389
(46235355) HIV 1 and 2 tests - Meaningful Use set
176
845
2.38
20.92
1.6
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
12
15.31
20.25
2.1
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
40
78
5.34
19.75
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
19
15
12.94
19.49
2.1
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
644
5144
2.16
18.42
15.3
7.6
u/l
84.9
80.3
1.48
626
4808
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
120
511
2.58
18.34
1.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
456
3239
1.92
18.25
8.1
5.5
e9/l
0.6
0.6
0.08
408
2793
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
128
4.09
17.76
2.1
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
29
46
6.50
17.65
1.9
2.1
e6/l
277.6
766.3
—
7
19
(3006315) Basophils [#/volume] in Blood
455
3255
1.89
17.55
8.1
5.5
e9/l
0.0
0.0
1.91
406
2814
(3007853) Bacteria identified in Skin by Aerobe culture
163
814
2.25
17.41
1.8
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
461
3320
1.88
17.33
8.1
5.6
e9/l
1.6
1.9
2.14
418
2907
(3002030) Lymphocytes/100 leukocytes in Blood
441
3132
1.88
17.31
8.4
5.9
%
24.0
27.0
5.53
418
2924
(3022096) Basophils/100 leukocytes in Blood
425
2984
1.88
17.29
8.4
5.7
%
0.6
0.7
0.53
405
2793
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
123
4.08
17.03
4.1
6.4
iu/ml
209.7
306.1
—
6
20
(3003458) Phosphate [Moles/volume] in Serum or Plasma
178
935
2.15
16.71
6.2
5.5
mmol/l
1.1
1.0
0.50
171
852
(3019069) Monocytes/100 leukocytes in Blood
432
3072
1.86
16.65
8.6
6.0
%
9.4
8.8
2.72
413
2885
(3013115) Eosinophils [#/volume] in Blood
461
3357
1.85
16.35
8.6
5.7
e9/l
0.2
0.2
0.02
417
2945
(3006504) Eosinophils/100 leukocytes in Blood
427
3060
1.82
15.73
8.4
5.7
%
2.8
2.8
0.26
406
2861
(3018010) Neutrophils/100 leukocytes in Blood
426
3079
1.80
14.99
8.0
5.7
%
59.2
57.8
1.33
407
2890
(3042111) Morphology [Interpretation] in Bone marrow Narrative
45
125
3.75
14.29
1.4
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
179
3.22
13.72
2.1
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
269
1752
1.80
13.01
3.8
2.8
umol/l
3279.7
8928.9
1.55
250
1494
(3013826) Glucose [Moles/volume] in Serum or Plasma
515
4030
1.74
12.91
6.4
5.1
mmol/l
6.7
6.8
0.20
501
3786
(36304419) Bacteria [Presence] in Urine
283
1888
1.76
12.51
3.0
3.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
41
118
3.60
12.38
2.7
3.8
%
2.6
1.3
1.04
33
100
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
185
3.05
12.37
2.1
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
14
14
10.16
12.26
1.6
2.1
e6/l
760.0
664.0
—
9
5
(3030467) Casts [#/volume] in Urine by Automated count
290
1960
1.74
12.18
3.1
3.3
e6/l
0.6
0.5
0.35
229
1498
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
200
1219
1.85
11.87
2.2
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
142
775
2.01
11.73
2.9
2.8
umol/l
10.3
9.0
0.27
129
682
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
82
4.02
11.38
1.8
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
259
2.64
11.28
2.9
2.8
u/ml
0.3
0.4
0.37
45
151
(3021589) Normoblasts [#/volume] in Blood
389
2897
1.65
11.06
15.8
9.8
e9/l
0.0
0.0
0.61
334
2378
(3003694) ABO and Rh group [Type] in Blood
253
1686
1.72
10.96
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
150
859
1.91
10.72
1.9
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
100
3.61
10.69
1.7
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
180
1097
1.82
10.56
2.6
2.0
s
29.9
29.9
0.01
172
1061
(3014576) Chloride [Moles/volume] in Serum or Plasma
157
918
1.88
10.51
7.1
6.7
mmol/l
105.0
104.3
1.08
152
895
(3005719) IgG [Mass/volume] in Serum or Plasma
100
501
2.13
10.35
4.2
2.9
g/l
9.3
10.8
2.12
94
460
(3017181) Myelocytes/100 leukocytes in Blood
109
565
2.07
10.32
4.2
4.2
%
1.4
1.0
0.66
60
182
(3002582) Erythrocytes [#/volume] in Urine
302
2138
1.65
10.29
3.2
3.4
e6/l
34.6
99.9
1.23
236
1667
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
149
866
1.88
10.14
1.9
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
114
605
2.03
10.12
9.2
8.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
157
2.97
10.01
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
743
1.93
9.89
5.4
3.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
22
6.93
9.76
1.3
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
37
5.23
9.39
1.9
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
19
37
5.23
9.39
1.9
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
331
2444
1.59
9.26
3.6
3.9
e6/l
96.1
93.5
0.03
248
1781
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
58
4.23
9.23
2.0
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
27
6.02
9.15
1.9
1.3
ug/l
1.8
3.2
—
10
22
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
46
4.66
9.10
1.9
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
207
2.61
9.06
1.6
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
172
2.77
9.04
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
145
866
1.82
8.99
7.2
7.8
mmol/l
0.5
1.4
1.31
115
669
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
129
743
1.87
8.98
3.1
4.2
ug/l
11.6
33.4
0.95
101
632
(3021440) Promyelocytes/100 leukocytes in Blood
100
530
2.01
8.89
4.3
4.3
%
0.2
0.1
0.36
57
164
(3002179) Metamyelocytes/100 leukocytes in Blood
95
503
2.00
8.46
4.4
4.2
%
0.8
0.5
1.72
46
131
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
101
3.26
8.43
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
67
3.82
8.39
1.9
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
82
3.50
8.28
2.7
4.5
—
—
—
0
0
(3026782) Osmolality of Urine
208
1408
1.64
8.14
2.5
2.9
mosm/kgh2o
514.3
561.1
2.50
176
1210
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
100
3.18
7.90
1.6
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
138
847
1.76
7.75
2.3
2.6
%
1.7
1.8
0.52
126
767
(3004588) Protein electrophoresis panel - Serum or Plasma
93
507
1.94
7.61
4.1
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
215
1489
1.60
7.60
2.5
2.7
e6/l
6.4
4.6
1.25
185
1321
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
333
2552
1.51
7.45
3.3
3.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
116
2.92
7.29
1.7
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
134
2.76
7.17
1.6
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
76
395
2.02
7.13
8.1
11.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
125
2.79
6.94
4.2
3.5
%
60.7
59.1
0.27
34
125
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
109
2.92
6.86
2.1
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
520
4419
1.48
6.65
4.7
4.8
e6/l
52.4
2775.7
—
8
76
(3023520) Reticulocytes [#/volume] in Blood
106
631
1.78
6.58
2.6
2.5
e9/l
67.0
69.1
0.25
84
494
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
102
602
1.79
6.51
2.3
2.3
u/l
61.8
32.2
0.64
87
512
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
33
4.61
6.48
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
60
3.57
6.47
1.3
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
88
499
1.86
6.40
4.3
4.3
%
0.0
0.8
0.59
46
139
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
120
2.73
6.31
3.6
3.1
e9/l
4.3
4.4
0.12
32
120
(3023323) Follitropin [Units/volume] in Serum or Plasma
36
144
2.57
6.27
1.5
1.4
iu/l
27.0
26.8
0.01
28
118
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
176
1212
1.58
6.25
2.8
2.8
e6/l
1.3
1.1
0.40
103
715
(40765096) Chromosome analysis panel by Banding
13
26
5.06
6.24
1.4
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
96
567
1.78
6.12
4.6
3.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
8
12.63
6.09
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
57
285
2.07
5.96
3.3
3.4
u/ml
93.0
13938.7
0.82
47
245
(3000494) Fungus identified in Specimen by Culture
127
817
1.66
5.95
1.6
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
25
85
3.00
5.88
1.2
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
709
6501
1.66
5.86
28.3
15.7
mg/l
30.1
25.7
2.59
645
5238
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
150
2.46
5.78
1.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
263
2.09
5.66
1.8
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
29
4.54
5.52
3.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
29
4.54
5.52
3.2
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
164
1143
1.54
5.48
2.9
3.1
e6/l
3.1
2.0
0.66
90
650
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
64
346
1.92
5.40
5.5
4.0
mmol/l
24.0
24.2
0.30
58
313
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
30
4.39
5.31
3.2
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
151
2.38
5.24
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
151
2.38
5.24
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
189
1371
1.49
5.21
6.1
4.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
86
517
1.74
5.17
4.2
2.8
ml/min/173m2
57.5
61.9
0.34
31
226
(40760888) Immunoglobulin light chains.free panel - Serum
39
178
2.25
5.14
6.2
4.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
93
2.74
5.04
1.2
1.3
e6/l
929.6
1687.7
1.22
17
64
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
140
959
1.55
5.03
2.5
2.5
%
22.7
22.4
0.10
124
810
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
99
2.68
5.02
2.0
1.4
u/ml
95.4
90.8
—
5
15
(3004789) Transferrin [Mass/volume] in Serum or Plasma
146
1011
1.54
5.00
2.4
2.4
g/l
2.1
2.3
2.76
138
939
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
77
2.91
4.95
2.6
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
51
3.38
4.90
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
72
2.97
4.90
2.7
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
89
2.75
4.88
1.6
2.0
u/l
39.7
3727.3
—
6
29
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
188
1380
1.47
4.85
3.4
4.0
ng/l
247.8
353.7
0.35
157
1129
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
269
2112
1.41
4.81
4.4
3.3
u/l
33.1
34.0
0.19
256
2008
(3022948) Iron [Moles/volume] in Serum or Plasma
156
1105
1.51
4.80
2.4
2.5
umol/l
12.2
12.7
0.31
144
1023
(3009214) Lutropin [Units/volume] in Serum or Plasma
31
132
2.40
4.79
1.4
1.3
u/l
10.4
9.3
0.17
25
100
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
85
2.75
4.71
1.2
1.3
e6/l
24080.0
112702.5
0.62
15
48
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
92
580
1.66
4.65
9.6
3.8
mmol/l
1.2
1.2
0.31
87
502
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
213
2.08
4.65
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
75
2.85
4.58
1.2
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
11
8.26
4.57
2.0
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
8
10.08
4.52
3.0
7.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
8
10.08
4.52
1.5
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
72
432
1.73
4.37
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
530
4688
1.37
4.35
4.5
4.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
73
2.78
4.21
3.3
3.7
%
65.3
55.0
1.19
13
55
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
41
3.46
4.20
1.9
3.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
45
241
1.92
3.96
6.7
3.9
mg/l
50.7
85.7
0.52
36
195
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
187
1420
1.41
3.96
2.3
1.7
mg/l
2.3
1.3
0.96
159
1117
(3002385) Erythrocyte distribution width [Ratio]
586
5304
1.37
3.91
34.0
19.1
%
14.2
13.8
9.18
576
5198
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
45
242
1.91
3.91
6.7
3.9
mg/l
60.5
34.8
0.31
36
198
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
38
3.46
3.91
3.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
38
3.46
3.91
3.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
38
3.46
3.91
3.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
38
3.46
3.91
3.2
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
265
1.86
3.86
3.4
2.6
g/l
3.6
3.2
1.23
38
206
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
54
311
1.79
3.80
2.3
1.8
ug/l
0.9
2.3
0.67
49
275
(3019550) Sodium [Moles/volume] in Serum or Plasma
719
6759
1.51
3.74
29.1
18.7
mmol/l
139.2
139.6
4.70
708
6578
(40768806) Pleura Pathology biopsy report
22
91
2.46
3.66
1.1
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
27
123
2.24
3.64
1.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
46
3.08
3.54
1.6
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
606
6508
0.74
3.49
4.6
5.1
mmol/l
2.7
2.7
0.29
528
5904
(3023103) Potassium [Moles/volume] in Serum or Plasma
719
6778
1.49
3.48
29.5
18.8
mmol/l
4.0
4.0
2.50
708
6590
(1616796) Gas panel - Central venous blood
30
146
2.09
3.46
2.2
3.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
100
691
1.51
3.45
4.7
3.8
mmol/l
1.5
2.0
0.87
80
551
(3012501) Base excess in Blood by calculation
31
153
2.07
3.44
3.5
4.1
mmol/l
3.2
2.6
0.44
25
102
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
48
2.95
3.31
3.3
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
261
2142
1.32
3.30
2.6
2.5
u/l
55.3
56.4
0.14
244
1976
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
33
172
1.96
3.18
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
588
6319
0.76
3.16
4.0
4.5
mmol/l
1.4
1.4
2.15
507
5730
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
283
1.74
3.16
3.4
2.6
g/l
4.3
3.7
0.50
38
202
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
593
6363
0.76
3.13
4.1
4.6
mmol/l
4.5
4.5
0.02
521
5820
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
284
1.73
3.12
3.4
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
284
1.73
3.12
3.4
2.6
g/l
7.8
7.5
0.47
40
210
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
20
4.54
3.12
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
68
2.53
3.05
1.2
1.2
u/l
55.3
51.4
0.16
12
47
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
5
10.05
2.98
1.2
5.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
709
6706
1.42
2.98
23.6
15.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
69
2.49
2.97
2.8
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
69
2.49
2.97
2.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
69
2.49
2.97
2.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
623
5781
1.32
2.93
28.6
16.9
%
38.0
39.4
3.73
420
3873
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
194
1.84
2.84
1.3
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
90
2.25
2.82
3.2
1.9
%
87.5
89.9
0.57
20
90
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
263
1.71
2.79
3.6
2.7
g/l
11.3
10.5
0.28
38
223
(3052851) Hemolysis interference index of Serum or Plasma
34
188
1.84
2.78
4.1
3.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
647
6052
1.32
2.76
26.8
14.7
ml/min/173m2
80.6
77.3
3.23
588
4987
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
105
2.13
2.71
1.6
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
259
2172
1.28
2.70
3.1
3.3
—
—
—
0
0
(3000012) Reticulocyte production index
11
37
3.00
2.70
1.4
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
24
3.78
2.67
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
47
290
1.66
2.66
2.9
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
106
2.11
2.65
1.4
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
141
1.95
2.63
1.0
1.2
e6/l
34.1
47.9
0.11
22
108
(3037467) Urinalysis macro (dipstick) panel - Urine
504
4581
1.26
2.63
4.3
4.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
452
1.53
2.62
2.3
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
568
6088
0.78
2.62
3.8
4.1
mmol/l
1.3
1.3
1.07
488
5487
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
15
4.70
2.60
2.4
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
29
156
1.89
2.60
1.0
1.3
mg/l
644.3
481.6
1.05
29
148
(3013707) Erythrocyte sedimentation rate by Westergren method
531
4861
1.26
2.58
4.7
4.2
mm/h
16.6
13.0
3.30
482
4445
(3008536) Aspergillus sp Ab [Presence] in Serum
8
20
4.03
2.57
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
50
2.63
2.54
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
63
2.41
2.47
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
45
2.69
2.46
4.6
3.2
—
—
—
0
0
(3020891) Body temperature
47
297
1.62
2.44
4.3
4.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
27
3.36
2.39
1.1
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
46
291
1.62
2.39
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
8
6.28
2.37
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
84
2.17
2.36
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
59
2.40
2.30
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
85
2.14
2.30
1.5
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
106
2.01
2.27
1.7
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
106
2.01
2.27
1.9
2.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
86
2.12
2.24
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
86
2.12
2.24
1.5
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
73
2.22
2.22
1.1
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
9
5.58
2.21
6.2
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
151
1.81
2.18
1.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
101
2.00
2.17
1.4
1.2
u/ml
318.0
268.1
—
10
55
(3025941) Bacteria identified in Stool by Culture
51
342
1.52
2.09
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
20
3.52
2.06
2.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
176
2107
0.79
2.05
3.0
3.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
49
330
1.52
1.99
1.4
2.0
g/l
2.0
1.5
1.12
41
290
(3037756) Immunofixation for Serum or Plasma
28
164
1.73
1.97
3.7
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
21
3.35
1.97
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
149
1.77
1.96
3.3
2.7
%
14.3
16.1
—
10
77
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
11
4.57
1.94
6.0
2.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
11
4.57
1.94
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
33
2.75
1.93
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
33
2.75
1.93
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
85
2.02
1.91
1.5
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
79
588
1.38
1.91
2.2
2.0
nmol/l
374.6
379.0
0.07
73
539
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
51
0.00
1.89
0.0
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
22
3.20
1.88
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
22
3.20
1.88
1.1
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
72
2.10
1.87
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
86
2.00
1.86
1.5
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
258
2244
1.22
1.85
3.4
3.2
ng/l
2063.9
1539.6
0.93
231
1954
(3034426) Prothrombin time (PT)
6
17
3.55
1.84
1.2
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
17
3.55
1.84
1.5
2.7
%
210.8
137.9
—
6
17
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
24
138
1.76
1.81
1.0
1.2
mmol/l
3.8
3.8
0.08
24
130
(3003327) Ova and parasites identified in Stool by Light microscopy
30
184
1.65
1.81
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
71
525
1.39
1.79
3.9
5.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
47
2.36
1.78
1.1
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
67
2.11
1.76
2.4
2.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
74
2.05
1.76
1.5
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
18
3.35
1.75
1.5
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
163
1.68
1.73
1.6
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
30
2.68
1.72
2.3
2.2
u/ml
821.9
1003.2
—
8
30
(21494890) Protein electrophoresis panel - 24 hour Urine
15
75
2.02
1.70
3.9
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
74
969
0.74
1.70
1.2
1.2
u/ml
19.5
11.1
0.35
25
357
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
714
6882
1.29
1.66
18.4
10.7
u/l
26.9
25.9
1.07
693
6617
(3011397) Hemoglobin [Presence] in Urine by Test strip
180
1526
1.23
1.65
3.6
3.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
132
0.38
1.63
1.4
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
5
14
3.59
1.61
1.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
43
2.34
1.60
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
43
2.34
1.60
1.3
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
26
2.71
1.58
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
87
679
1.31
1.57
5.9
4.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
50
2.22
1.57
1.1
1.0
—
—
—
0
0
(44806118)
17
92
1.87
1.57
1.2
1.5
—
—
—
0
0
(44790049)
17
92
1.87
1.57
1.2
1.5
—
—
—
0
0
(44790048)
17
92
1.87
1.57
1.2
1.5
—
—
—
0
0
(44790047)
17
92
1.87
1.57
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
39
265
1.50
1.56
2.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
78
1.94
1.55
4.5
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
100
1.82
1.54
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
82
639
1.31
1.51
2.5
3.2
ng/l
277.6
242.9
0.27
75
587
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
94
1.83
1.48
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
38
2.38
1.46
3.2
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
299
2687
1.18
1.45
2.7
2.8
ug/l
345.9
143.0
2.00
279
2444
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
59
2.05
1.44
1.2
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
16
3.14
1.44
1.2
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
22
2.74
1.43
3.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
576
6043
0.84
1.43
5.7
6.2
mmol/mol
40.2
40.4
0.20
499
5555
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
165
1.59
1.41
1.1
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
239
2113
1.18
1.40
2.7
2.1
u/l
160.5
254.6
1.57
227
1979
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
443
0.66
1.40
1.6
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
29
2.43
1.39
5.1
5.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
29
2.43
1.39
1.0
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
119
986
1.24
1.36
24.9
27.2
inr
1.7
1.4
0.70
11
131
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
69
534
1.32
1.35
3.6
3.5
ng/l
95.0
84.9
0.47
56
459
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
68
1.93
1.34
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
9
43
2.10
1.30
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
62
1.95
1.28
1.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
203
1784
1.18
1.27
4.6
4.2
estimate
0.0
0.0
0.50
80
593
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
35
2.30
1.27
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
111
1327
0.81
1.26
1.3
1.2
u/ml
0.6
1.9
2.73
17
348
(3006462) Nitrate [Presence] in Urine
6
25
2.41
1.24
2.2
3.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
70
1.87
1.24
1.0
1.3
nmol/l
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
204
1.49
1.24
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
45
2.01
1.23
1.8
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
19
2.64
1.21
1.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
140
1.59
1.21
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
154
1774
0.84
1.20
1.6
1.6
mmol/l
1.3
1.3
0.51
117
1462
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
168
0.53
1.19
1.8
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
439
0.69
1.19
1.9
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
206
1.47
1.19
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
427
0.69
1.19
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
299
1.39
1.19
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
64
1.89
1.18
4.8
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
207
1.47
1.16
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
33
0.00
1.16
0.0
18.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
401
0.69
1.15
1.6
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
60
468
1.30
1.14
3.5
4.3
mmol/l
2.9
1.7
1.33
49
350
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
201
1782
1.17
1.13
2.1
2.2
mg/l
3.2
3.1
0.08
169
1512
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
40
2.01
1.12
2.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
135
1.57
1.12
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
88
1.72
1.12
1.0
1.2
u/ml
2.6
6.3
—
7
41
(3019832) Treponema pallidum Ab [Presence] in Serum
48
364
1.34
1.11
1.8
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
349
3231
1.14
1.07
4.9
5.3
estimate
0.0
0.0
0.00
85
609
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
74
1.77
1.07
1.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
203
0.59
1.04
2.3
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
22
2.28
1.03
1.0
1.0
miu/ml
2155.8
1651.2
—
5
22
(3014051) Protein [Presence] in Urine by Test strip
21
140
1.51
0.98
2.7
2.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
622
0.77
0.96
1.6
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
732
7154
1.21
0.96
40.1
22.9
fl
91.3
91.3
0.08
721
7039
(3035941) MCH [Entitic mass]
732
7154
1.21
0.96
40.0
22.8
pg
30.2
30.4
1.34
721
7038
(3009261) Glucose [Presence] in Urine by Test strip
351
3270
1.13
0.95
4.0
3.9
estimate
0.0
0.0
0.50
84
594
(3026361) Erythrocytes [#/volume] in Blood
732
7155
1.21
0.95
40.2
22.9
e12/l
4.3
4.5
17.99
712
6941
(3035350) Ketones [Presence] in Urine by Test strip
347
3231
1.13
0.95
3.9
3.9
estimate
0.0
0.0
0.00
89
620
(3010813) Leukocytes [#/volume] in Blood
732
7156
1.21
0.94
40.2
23.0
e9/l
7.1
6.8
0.73
711
6940
(4268621)
11
62
1.78
0.94
2.1
2.2
—
—
—
0
0
(3009343) pH of Capillary blood
61
491
1.26
0.94
3.6
4.2
ph
7.5
7.4
—
8
62
(3000963) Hemoglobin [Mass/volume] in Blood
732
7158
1.21
0.93
40.4
23.1
g/l
127.5
134.8
25.98
723
7036
(40768793) Breast Pathology biopsy report
20
134
1.50
0.92
1.3
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
731
7151
1.20
0.90
40.3
22.9
e9/l
247.9
243.6
0.83
711
6960
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
135
1.49
0.89
1.9
1.7
iu/l
8.2
5.3
—
7
41
(4211845)
6
29
2.08
0.89
2.2
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
103
1.56
0.88
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
43
1.87
0.87
2.8
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
612
6316
0.88
0.87
4.5
4.8
mmol/l
6.1
6.0
0.38
533
5677
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
367
0.73
0.87
2.4
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
23
162
1.43
0.85
1.2
1.2
—
63.3
—
0
12
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
80
1.64
0.85
1.3
1.1
g/l
1.6
1.5
0.75
13
73
(3022145) Colonoscopy Study observation
87
738
1.20
0.84
1.4
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
554
5325
1.12
0.84
36.0
20.6
g/l
330.4
332.3
4.63
546
5287
(4306422)
12
73
1.65
0.82
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
41
321
1.29
0.81
4.6
3.2
pmol/l
4.6
4.5
0.06
36
275
(3020961) Endomysium IgA Ab [Titer] in Serum
20
280
0.71
0.78
1.1
1.1
—
86.4
—
0
8
(3037522) Nuclear Ab [Titer] in Serum
68
805
0.83
0.75
1.2
1.3
titre
664.0
428.7
0.32
15
170
(40768797) Stomach Pathology biopsy report
104
909
1.16
0.73
1.3
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
25
2.01
0.72
1.2
1.2
mmol/l
2.7
4.4
—
5
20
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
25
2.01
0.72
1.0
1.1
iu/ml
129.6
188.0
—
5
25
(4062490)
9
56
1.61
0.72
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
194
0.66
0.71
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
134
1197
1.14
0.71
2.0
1.5
g/l
2.2
2.5
1.42
91
713
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
26
1.93
0.70
1.6
1.2
mmol/l
6.0
6.8
—
5
26
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
26
1.93
0.70
1.0
1.1
%
16.0
30.4
—
5
20
(3004451) EKG impression Narrative
7
41
1.71
0.70
1.1
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
650
1.19
0.70
2.4
2.5
ug/l
6.2
6.5
0.07
70
575
(3013512) EKG study
225
2082
1.11
0.67
4.0
4.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
394
0.78
0.66
2.9
3.0
e6/l
0.9
0.3
0.36
31
381
(3021788) Differential panel - Synovial fluid
18
128
1.42
0.66
1.4
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
282
2647
1.10
0.63
2.2
2.2
nmol/l
75.6
77.9
0.67
246
2326
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
156
1.36
0.61
2.1
2.3
g/l
114.9
128.6
1.13
13
115
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
75
861
0.86
0.60
4.3
4.7
%
30.5
32.1
0.76
48
561
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
1018
0.87
0.60
1.2
1.3
iu/ml
35.4
38.7
0.09
30
316
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
54
1.49
0.57
5.0
2.4
%
12.0
9.9
—
8
54
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
81
1.49
0.57
2.5
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
122
0.65
0.55
1.1
1.2
—
—
—
0
0
(4281824)
9
61
1.48
0.54
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
204
0.73
0.53
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
268
1.24
0.53
2.1
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
6
39
1.54
0.53
4.8
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
132
0.68
0.52
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
127
1391
0.90
0.52
1.9
1.8
nmol/l
1198.6
1202.0
0.01
87
1047
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
137
1493
0.90
0.51
1.5
1.7
pmol/l
441.6
14131774.8
1.04
105
1203
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
118
1.36
0.50
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
186
1733
1.09
0.49
1.5
1.6
nmol/l
19.8
20.5
0.21
160
1450
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
409
0.82
0.48
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
136
1477
0.91
0.48
4.3
4.3
kg/l
1.0
1.0
0.76
21
221
(1761482) Bacteria [#/volume] in Urine by Culture
16
211
0.75
0.48
3.9
5.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
58
664
0.86
0.47
1.4
1.8
%
1.5
1.5
0.48
49
568
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
47
1.49
0.47
1.0
1.1
mg/l
276.6
280.1
—
7
41
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
2743
1.08
0.45
3.8
4.0
ng/l
35.2
41.2
0.48
242
2044
(3025130) Human papilloma virus identified in Specimen
7
50
1.40
0.45
3.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
78
1.42
0.43
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
207
0.77
0.43
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
32
1.57
0.42
2.4
1.4
—
—
—
0
0
(4024509)
8
58
1.38
0.41
1.3
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
16
0.00
0.41
0.0
5.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
293
0.81
0.41
1.7
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
79
1.40
0.41
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
8
60
1.34
0.40
1.1
1.0
—
2.4
—
0
15
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
68
1.33
0.37
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
204
2151
0.93
0.37
4.7
4.5
%
22.9
21.5
0.69
114
1078
(3024263) Appearance of Synovial fluid
5
37
1.35
0.37
1.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
116
0.69
0.37
1.1
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
70
1.29
0.36
1.1
1.5
—
—
—
0
0
(3000492) Spirometry study
62
555
1.13
0.36
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
94
863
1.10
0.36
11.7
7.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
190
0.79
0.36
1.6
2.5
ug/min
29.3
107.0
—
8
112
(3001019) Free T4 and TSH panel - Serum or Plasma
16
200
0.80
0.34
1.3
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
40
349
1.15
0.34
3.1
3.8
%
50.1
48.6
0.14
40
344
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
297
0.84
0.34
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
163
1.23
0.34
3.8
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
45
1.34
0.34
2.2
3.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
14
177
0.79
0.33
1.6
1.7
e6/l
10773.8
17553.6
—
9
132
(3020682) Albumin/Creatinine [Ratio] in Urine
210
2201
0.94
0.33
3.4
4.0
mg/mmol
5.4
9.5
1.76
128
1413
(3037121) Protein [Mass/volume] in Urine
30
257
1.17
0.32
4.5
3.2
g/l
0.3
0.3
0.08
21
102
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
119
1.27
0.32
2.8
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
422
4109
1.06
0.32
3.3
3.2
u/l
58.1
52.4
0.43
392
3794
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
131
0.76
0.31
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
138
1.24
0.30
2.2
3.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
167
1756
0.94
0.29
4.0
3.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
21
176
1.20
0.29
2.8
3.1
nmol/l
1.1
0.9
0.25
16
145
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
21
176
1.20
0.29
1.1
2.0
mg/l
10.1
12.5
0.56
21
159
(1002224) Polysomnography panel
19
227
0.83
0.28
1.1
1.1
—
—
—
0
0
(4034850)
18
216
0.83
0.28
10.6
13.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
146
1540
0.94
0.28
3.1
3.2
ug/l
0.7
0.8
0.44
112
1046
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
214
1.17
0.28
1.9
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
495
4852
1.05
0.27
3.8
3.8
pmol/l
14.9
15.0
0.43
438
4341
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
347
1.13
0.27
1.1
1.2
iu/ml
120.4
131.3
0.07
13
132
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
122
1.23
0.27
1.1
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
113
1.24
0.26
1.2
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
72
1.25
0.25
1.6
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
277
2852
0.96
0.23
1.9
2.1
pmol/l
92.8
94.1
0.16
159
1474
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
40
1.25
0.22
1.2
1.0
—
1.1
—
0
12
(3022621) pH of Urine by Test strip
40
440
0.90
0.22
3.4
3.1
—
—
—
0
0
(44813793)
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.9
—
0
10
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
67
718
0.93
0.21
2.3
2.2
ug/g
151.4
132.7
0.14
60
563
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
43
1.16
0.21
1.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
43
1.16
0.21
1.4
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
18.6
—
0
13
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
49
1.23
0.20
1.5
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
49
1.23
0.20
1.5
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
133
0.82
0.19
1.0
1.4
nmol/l
0.5
0.8
1.11
11
112
(3022313) Gas panel - Capillary blood
40
367
1.09
0.18
4.2
4.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
193
0.88
0.16
1.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
151
0.86
0.16
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
130
1.16
0.15
1.7
1.4
miu/ml
124.7
230.9
—
6
52
(3050129) First trimester maternal screen panel - Serum or Plasma
6
77
0.78
0.15
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
77
0.78
0.15
1.8
2.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
20
178
1.13
0.15
2.1
1.8
nmol/l
36.8
40.1
0.29
20
170
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
389
0.92
0.15
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
83
1.09
0.14
1.0
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
592
5867
1.03
0.14
4.5
4.7
mu/l
1.9
2.2
0.81
521
5287
(3011288) Drugs identified in Urine by Screen method
8
97
0.82
0.13
1.3
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
258
2528
1.03
0.13
4.3
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
92
884
1.05
0.13
1.4
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
190
1.11
0.13
1.6
1.5
iu/ml
1.4
0.1
—
7
38
(3017732) Neutrophils [#/volume] in Blood
43
405
1.07
0.12
2.3
2.7
e9/l
3.9
4.1
0.17
32
306
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
270
2654
1.03
0.11
5.0
5.3
ug/l
2.9
3.0
0.09
238
2367
(40768800) Prostate Pathology biopsy report
15
167
0.90
0.10
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
197
0.91
0.10
2.1
1.7
mg/l
6.1
2.9
0.41
12
145
(40761535) Cells panel - Urine sediment
64
615
1.04
0.09
4.2
3.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
155
0.90
0.09
3.1
3.7
mg/l
67.3
27.5
—
7
101
(4010399)
51
488
1.05
0.09
1.3
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
34
322
1.06
0.08
2.9
2.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
67
1.05
0.08
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
138
1.09
0.06
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
100
0.90
0.06
1.1
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
454
1.04
0.06
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
220
2175
1.02
0.05
2.8
3.1
mmol/l
7.1
7.5
0.64
180
1804
(3000330) Specific gravity of Urine by Test strip
37
356
1.04
0.05
3.5
4.2
—
—
—
0
0
(4094501)
15
160
0.94
0.04
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
357
3591
0.99
0.04
2.7
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
68
694
0.98
0.04
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
207
2086
0.99
0.03
2.8
3.2
mg/l
252.8
232.9
0.03
134
1364
(3044941) Cell count panel - Synovial fluid
12
113
1.06
0.02
1.6
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
113
1.06
0.02
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
105
0.95
0.00
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
113
0.97
0.00
2.0
2.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
203
0.98
0.00
1.4
1.5
ug/g
225.2
273.1
0.52
14
120
(3045424) Erythrocytes [Presence] in Urine
10
102
0.98
0.00
1.1
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
151
0.99
0.00
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
151
0.99
0.00
1.3
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
6.8
—
7.1
—
0
9
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
86.7
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
66
0.91
0.00
1.3
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
79
1.01
0.00
1.0
1.2
—
75.1
—
0
5
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
79.6
—
0
7
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
50
1.00
0.00
2.8
2.0
%
13.2
13.2
—
5
50
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.6
—
0
5
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.4
—
0
5
(3044927) Protein electrophoresis panel - Urine
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
53
0.94
0.00
1.2
1.4
—
242.9
—
0
7
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
150
1.00
0.00
1.3
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CONNECTIVE_SOFT_NAS – Malignant neoplasm of other connective and soft tissue
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).